Cited by 87Transcranial Magnetic Stimulation StudiesTreatment of Major DepressionElectroconvulsive Therapy Studies

A pilot investigation of an intensive theta burst stimulation protocol for patients with treatment resistant depression

Open access
Fitzgerald, Paul B., Chen, Leo, Richardson, Karyn, Daskalakis, Zafiris J., Hoy, Kate E.·2020·Brain Stimulation

Abstract

INTRODUCTION: Accelerated or intensive forms of repetitive transcranial magnetic stimulation (rTMS) are increasingly being explored for their potential to produce more efficient and rapid treatment benefits in major depressive disorder (MDD). However, accelerated or intensive protocols using standard forms of rTMS are still quite time-consuming to apply. Theta burst stimulation (TBS) is a novel form of magnetic stimulation with the potential to produce similar anti-depressant effects but in a much abbreviated period of time. The aim of this study was to investigate the comparative efficacy of an intensive TBS protocol compared to standard rTMS treatment. METHODS: 74 outpatients (36 female, mean age 44.36 ± 12.1 years) with MDD received either intensive TBS (3 intermittent TBS treatments per day for 3 days in week 1, 3 treatments a day for 2 days in week 2, and 3 treatments in 1 day in week 3 and in week 4, or standard rTMS (5 daily sessions per week for 4 weeks). Patients were assessed weekly throughout the treatment course, and at 4 weeks after treatment end. RESULTS: There were no significant differences in the degree of reduction in depressive symptoms, the rate of reduction in depressive symptoms, remission or response rates (response rates = 27.8% for intensive group, 26.3% for the standard group, p > 0.05 for all analyses) between the intensive TBS and standard rTMS treatment groups. However, the overall response and remission rates were limited in both groups. There was no difference in rates of side effects, no serious adverse events and no alterations in cognitive performance. CONCLUSION: Intensively applied TBS appears to have similar efficacy to standard rTMS when these were applied as delivered in this study but does not produce more rapid clinical benefits. The overall response rates in both groups in this study were limited, most likely by the total doses provided in both study arms. CLINICAL TRIALS REGISTRATION: Australian New Zealand Clinical Trials Registry: ACTRN12616000443493.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.brs.2019.08.013

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 30

  1. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405e18.
  2. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Co- morbidity Survey Replication (NCS-R). J Am Med Assoc 2003;289:3095e105.
  3. Simon GE. Social and economic burden of mood disorders. Biol Psychiatry 2003;54:208e15.
  4. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psy- chiatry 2003;53:649e59.
  5. Fitzgerald PB, Daskalakis ZJ. The effects of repetitive transcranial magnetic stimulation in the treatment of depression. Expert Rev Med Devices 2011;8: 85e95.
  6. Baeken C, Vanderhasselt MA, Remue J, Herremans S, Vanderbruggen N, Zeeuws D, et al. Intensive HF-rTMS treatment in refractory medication- resistant unipolar depressed patients. J Affect Disord 2013;151:625e31.
  7. Fitzgerald PB, Hoy KE, Elliot D, Susan McQueen RN, Wambeek LE, Daskalakis ZJ. Accelerated repetitive transcranial magnetic stimulation in the treatment of depression. Neuropsychopharmacology 2018;43:1565e72.
  8. Chung SW, Hoy KE, Fitzgerald PB. Theta-burst stimulation: a new form of TMS treatment for depression? Depress Anxiety 2015;32:182e92.
  9. Huang Y, Edwards M, Rounis E, Bhatia K, Rothwell J. Theta burst stimulation on the human motor cortex. Neuron 2005;45:201e6.
  10. Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 2018;391:1683e92.
  11. Duprat R, Desmyter S, Rudi de R, van Heeringen K, Van den Abbeele D, Tandt H, et al. Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: a fast road to remission? J Affect Disord 2016;200:6e14.
  12. Schulze L, Feffer K, Lozano C, Giacobbe P, Daskalakis ZJ, Blumberger DM, et al. Number of pulses or number of sessions? An open-label study of trajectories of improvement for once-vs. twice-daily dorsomedial prefrontal rTMS in major depression. Brain Stimul 2018;11:327e36.
  13. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382e9.
  14. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in pa- tients with chronic major depression. Biol Psychiatry 2003;54:573e83.
  15. Hawley CJ, Gale TM, Sivakumaran T. Hertfordshire neuroscience research defining remission by cut off score on the MADRS: selecting the optimal value. J Affect Disord 2002;72:177e84.
  16. Johnson JA, Coons SJ, Ergo A, Szava-Kovats G. Valuation of EuroQOL (EQ-5D) health states in an adult US sample. PharmacoEconomics 1998;13:421e33.
  17. Partington J. Trail making test. Psychol Serv Cent Bull 1949;1:9e20.
  18. Fitzgerald PB, Brown TL, Daskalakis ZJ. The application of transcranial mag- netic stimulation in psychiatry and neurosciences research. Acta Psychiatr Scand 2002;105:324e40.
  19. Perera T, George MS, Grammer G, Janicak PG, Pascual-Leone A, Wirecki TS. The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimul 2016;9:336e46.
  20. Sverak T, Ustohal L. Efficacy and safety of intensive transcranial magnetic stimulation. Harv Rev Psychiatry 2018;26:19e26.
  21. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimu- lation: report and suggested guidelines from the international workshop on the safety of repetitive transcranial magnetic stimulation, june 5-7, 1996. Electroencephalogr Clin Neurophysiol 1998;108:1e16.
  22. Oberman L, Edwards D, Eldaief M, Pascual-Leone A. Safety of theta burst transcranial magnetic stimulation: a systematic review of the literature. J Clin Neurophysiol 2011;28:67e74.
  23. Rachid F. Safety and efficacy of theta-burst stimulation in the treatment of psychiatric disorders: a review of the literature. J Nerv Ment Dis 2017;205: 823e39.
  24. Murakami T, Muller-Dahlhaus F, Lu MK, Ziemann U. Homeostatic meta- plasticity of corticospinal excitatory and intracortical inhibitory neural circuits in human motor cortex. J Physiol 2012;590:5765e81.
  25. Tse NY, Goldsworthy MR, Ridding MC, Coxon JP, Fitzgerald PB, Fornito A, et al. The effect of stimulation interval on plasticity following repeated blocks of intermittent theta burst stimulation. Sci Rep 2018;8:8526.
  26. Chung SW, Rogasch NC, Hoy KE, Fitzgerald PB. The effect of single and repeated prefrontal intermittent theta burst stimulation on cortical reactivity and working memory. Brain Stimul 2018;11:566e74.
  27. Dong X, Yan L, Huang L, Guan X, Dong C, Tao H, et al. Repetitive transcranial magnetic stimulation for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2018;13: e0205704.
  28. Jiang Y, Guo Z, Xing G, He L, Peng H, Du F, et al. Effects of high-frequency transcranial magnetic stimulation for cognitive deficit in schizophrenia: a meta-analysis. Front Psychiatry 2019;10:135.
  29. Chung SW, Rogasch NC, Hoy KE, Sullivan CM, Cash RFH, Fitzgerald PB. Impact of different intensities of intermittent theta burst stimulation on the cortical properties during TMS-EEG and working memory performance. Hum Brain Mapp 2018;39:783e802.
  30. Thomson AC, de Graaf TA, Kenis G, Rutten BPF, Schuhmann T, Sack AT. No additive meta plasticity effects of accelerated iTBS with short inter-session intervals. Brain Stimul 2019;12(5):1301e3.

Cited by

Sorted by citations

Authors
Fitzgerald, P. B., Chen, L., Richardson, K., Daskalakis, Z. J., & Hoy, K. E.
Affiliations
  • Epworth Hospital (AU)
  • Centre for Addiction and Mental Health (CA)
Corresponding author
Fitzgerald, Paul B.
Venue
Brain Stimulation
Publisher
Elsevier BV
Published
2020-01
Volume
13
Issue
1
Pages
137-144
ISSN
  • 1876-4754 (ISSN-L)
  • 1935-861X
OpenAlex
W2969425970
Cited by
87
References
6
Citations by year
2026: 9 · 2025: 16 · 2024: 14 · 2023: 14 · 2022: 12 · 2021: 13 · 2020: 8 · 2019: 1
FWCI
3.74
Type
journal article
Language
en
Open access
Locations
  • Brain stimulation (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Monash University Research Portal (Monash University) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Health and Medical Research Council (1078567, 1082894)
  • Campbell Institute (1041890)
  • Centre for Addiction and Mental Health
  • Brain and Behavior Research Foundation
  • Canadian Institutes of Health Research
Topics
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
theta burst stimulation, repetitive transcranial magnetic stimulation, treatment-resistant depression, major depressive disorder, antidepressant efficacy, adverse effects, cognitive performance
MeSH terms
Adult, Female, Humans, Male, Middle Aged, Theta Rhythm, Transcranial Magnetic Stimulation, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review